by 2nd Smartest Guy in the World, 2nd Smartest Guy in the World:
Last year I published one of the most popular articles on Ivermectin and Cancer Treatment ever published, which went viral internationally:
(Oct.2, 2023) – IVERMECTIN and CANCER, it has at least 15 anti-cancer mechanisms of action. Can Ivermectin Treat COVID-19 mRNA Vaccine Induced Turbo Cancers? – 9 Ivermectin papers reviewed
TRUTH LIVES on at https://sgtreport.tv/
2024 – NEW STUDIES!
- (2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
- (2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
- (2024 Kaur et al) – Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy
- (2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma
- (2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
- (2024 Goldfarb et al) – Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities
- (2024 Newell et al) – Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy
PRACTICAL APPROACH TO USING IVERMECTIN IN CANCER TREATMENT (Disclaimer: the following is not medical advice)
In “Ivermectin and Cancer Part 1”, I covered all the mechanisms of action that Ivermectin has shown against cancer in many in vitro and in vivo studies.
The 7 new studies published in 2024 only confirm what we already know from previous studies. Ivermectin is highly effective against many cancers.
Since my previous Ivermectin article, I‘ve had 1000s of questions sent to me. Not about mechanisms of action against Cancer. But about practical use – how to use Ivermectin to treat Stage 4 Cancers, what formulations, what doses?
The goal of this article (Part 2) is to answer all of those questions to the best of my ability.

Papers reviewed:
- 2023 Sep.23 – Man-Yuan Li et al – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
- 2023 May – Samy et al – Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway
- 2022 Nov – Lotfalizadeh et al – The Anticancer potential of Ivermectin: Mechanisms of action and therapeutic implications
- 2022 Oct – Jian Liu et al – Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
- 2022 Jun – Daeun Lee et al – Ivermectin suppresses pancreatic cancer via mitochondria dysfunction
- 2021 Aug – Shican Zhou et al – Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
- 2021 Jan – Mingyang Tang et al – Ivermectin, a potential anticancer drug derived from an antiparasitic drug
- 2019 Sep Intuyod et al – Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
- 2018 Feb – Juarez et al – The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug
2018 Feb – Juarez et al – The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug
- Satoshi Omura at the Kitasato Institute discovered Ivermectin in 1979 and was awarded a Nobel Prize in Physiology or Medicine for this discovery in 2015
- Ivermectin was FDA Approved for human use in 1987 to orally treat onchocerciasis, also known as river blindness, caused by the blackfly-transmitted parasite Onchocerca volvulus
- Ivermectin is annually taken by close to 250 million people
- most patients treated with Ivermectin have no side-effects other than those caused by the immune and inflammatory responses against the parasite, such as fever, pruritus, skin rashes and malaise
- maximum concentration in plasma is reached 4-5 h after its oral administration
- its half-life is approximately 19 h and is metabolized in the liver by the cytochrome CYP1A and CYP3A4 complexes, generating 10 metabolites, mostly demethylated and hydroxylated.
- Its excretion is mainly by feces and only 1% is excreted in the urine
- Ivermectin exerts antitumor effects in different types of cancer.
Read More @ 2ndSmartestGuyintheWorld.com